Price $10.50 |
Market Cap
284.1M
|
Sector Health Care |
Div. Growth
-
|
P/E
-
|
P/B
-
|
P/S
0.79
|
Dividend %
-
|
P/CF
6.4
|
P/FCF
-
|
Op. Cash Flow
-5.1K
|
FCF
-0.3
|
Op. Margin
-16.60%
|
Net Margin
-28.20%
|
ROE
160.70%
|
ROI
-26.30%
|
ROA
-25.50%
|
EPS Growth
21.30%
|
Current Ratio
1.7
|
Debt/Equity
-
|
Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
---|---|---|---|---|---|
Spruce Biosciences Inc (SPRB) | $0.70 | - | - | 45.6M | Strong Buy |
ATI Physical Therapy Inc (ATIP) | $4.18 | - | - | 30.8M | Strong Buy |
Harvard Bioscience, Inc. (HBIO) | $3.56 | - | - | 183.6M | Strong Buy |
Titan Pharmaceuticals Inc (TTNP) | $6.97 | - | - | 6.5M | Strong Buy |
Myomo Inc (MYO) | $3.42 | - | - | 35.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More